Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04208048 · ClinicalTrials.gov registry record
FLXfitTM 15 TLIF Interbody Fusion Device
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 31
- Enrollment target
NCT04208048: Completed study, sponsored by Rush University Medical Center.
NCT04208048 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04208048 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is post-market, patient outcome research to evaluate medical device safety and effectiveness. The data collected will assess the safety of the FLXfit 15TM (studydevice) system.
Primary Outcome
Did patient achieve fusion?
Interventions
- DEVICE FLXfit 15TM device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-10-15 |
| Est. Completion | 2022-08-22 |
What the finished NCT04208048 record still lists
NCT04208048 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FLXfit 15TM device is the first listed.
NCT04208048 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04208048 about?
NCT04208048 is a clinical study titled "FLXfitTM 15 TLIF Interbody Fusion Device". The purpose of this study is post-market, patient outcome research to evaluate medical device safety and effectiveness. The data collected will assess the safety of the FLXfit 15TM (studydevice) system.
What is the current status of trial NCT04208048?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2018-10-15. Estimated completion is 2022-08-22.
What interventions are being tested in trial NCT04208048?
The interventions under investigation include: FLXfit 15TM device (DEVICE).
Who is sponsoring clinical trial NCT04208048?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI